These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30583821)

  • 1. Early local recurrence and one-year mortality of rectal cancer after restricting the neoadjuvant therapy regime.
    Tersteeg JJC; van Esch LM; Gobardhan PD; Kint PAM; Rozema T; Crolla RMPH; Schreinemakers JMJ
    Eur J Surg Oncol; 2019 Apr; 45(4):597-605. PubMed ID: 30583821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based guidelines for selective neoadjuvant treatment in rectal cancer: Does MRI adequately predict the indication for radiotherapy in daily practice in a large teaching hospital.
    Tersteeg JJC; Crolla RMPH; Gobardhan PD; Kint PAM; Niers-Stobbe I; Boonman-de Winter L; Arnold DE; Rozema T; Schreinemakers JMJ
    Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13190. PubMed ID: 31863608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
    Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
    World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.
    van Lingen CP; Zeebregts CJ; Gerritsen JJ; Mulder HJ; Mastboom WJ; Klaase JM
    Int J Gastrointest Cancer; 2003; 34(2-3):129-34. PubMed ID: 15361646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
    Gietelink L; Wouters MWJM; Marijnen CAM; van Groningen J; van Leersum N; Beets-Tan RGH; Tollenaar RAEM; Tanis PJ;
    Eur J Surg Oncol; 2017 Jul; 43(7):1297-1303. PubMed ID: 28351504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
    van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
    J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
    Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
    Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery.
    Klos CL; Shellito PC; Rattner DW; Hodin RA; Cusack JC; Bordeianou L; Sylla P; Hong TS; Blaszkowsky L; Ryan DP; Lauwers GY; Chang Y; Berger DL
    Am J Surg; 2010 Oct; 200(4):440-5. PubMed ID: 20887837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of lymphadenectomy in patients receiving neoadjuvant radiotherapy for rectal adenocarcinoma.
    Le M; Nelson R; Lee W; Mailey B; Duldulao M; Chen YJ; Garcia-Aguilar J; Kim J
    Ann Surg Oncol; 2012 Nov; 19(12):3713-8. PubMed ID: 22688661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
    Madbouly KM; Abbas KS; Hussein AM
    Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
    Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
    Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.